GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (LIM:TMO) » Definitions » 3-Year FCF Growth Rate

Thermo Fisher Scientific (LIM:TMO) 3-Year FCF Growth Rate : 1.50% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Thermo Fisher Scientific 3-Year FCF Growth Rate?

Thermo Fisher Scientific's Free Cash Flow per Share for the three months ended in Mar. 2024 was $2.35.

During the past 12 months, Thermo Fisher Scientific's average Free Cash Flow per Share Growth Rate was 36.40% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 1.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 15.10% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Thermo Fisher Scientific was 68.20% per year. The lowest was -123.70% per year. And the median was 14.50% per year.


Competitive Comparison of Thermo Fisher Scientific's 3-Year FCF Growth Rate

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific's 3-Year FCF Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's 3-Year FCF Growth Rate falls into.



Thermo Fisher Scientific 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Thermo Fisher Scientific  (LIM:TMO) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Thermo Fisher Scientific 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Thermo Fisher Scientific (LIM:TMO) Business Description

Address
168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).